Kevin Kauffman

Kevin Kauffman has a strong background in Chemical Engineering with a Doctor of Philosophy from Massachusetts Institute of Technology and a Bachelor of Science from The Ohio State University. Kevin has a wealth of experience in the biotech industry, with roles at Verseau Therapeutics and currently at Orna Therapeutics. During their time at Verseau, Kevin played a key role in establishing the lipid nanoparticle formulation platform and leading a macrophage checkpoint modulator program. Kevin also developed various immuno-assays and managed preclinical development for antibody programs. Kevin's expertise in the field has made him an invaluable asset in their roles as Associate Director, Principal Scientist, and Head of Delivery.